Literature DB >> 8785939

The three Rs of Russell & Burch and the testing of biological products.

M Balls1, D W Straughan.   

Abstract

The principles of humane animal experimentation proposed by Russell & Burch (1959), namely, replacement, reduction, and refinement, are now commonly known as the Three Rs. These principles are clearly embodied in Article 7 of Directive 86/609/EEC. It is instructive, therefore, to consider the priority currently attached to compliance with these principles and to the Directive in the development and control of biological products. Specific comments are made on the need for the application of the Three Rs in relation to the testing of human diphtheria and tetanus vaccines, human pertussis vaccine, inactivated veterinary Gumboro vaccine, veterinary Newcastle disease vaccine, veterinary clostridial vaccines and botulinum toxin. We pose three questions: a. Are the minimum numbers of animals already being used in this area? b. Is any unnecessary pain, suffering, distress or lasting harm being inflicted on the animals used? and c. What could and should be done about any shortcomings in current practice? Finally, the role of ECVAM in the promotion of the Three Rs within the European Union will be reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785939

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  3 in total

Review 1.  Refinement, reduction and replacement approaches to in vivo cardiovascular research.

Authors:  Michael Emerson
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Effects of Buprenorphine Treatment on Influenza Pathogenesis in the Ferret (Mustela putorius furo).

Authors:  Victoria J Mrotz; Kaitlyn M Nestor; Taronna R Maines; Nathaniel Powell; Jessica A Belser
Journal:  Comp Med       Date:  2022-02-01       Impact factor: 1.565

3.  Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices.

Authors:  Vanessa Neuhaus; Olga Danov; Sebastian Konzok; Helena Obernolte; Susann Dehmel; Peter Braubach; Danny Jonigk; Hans-Gerd Fieguth; Patrick Zardo; Gregor Warnecke; Christian Martin; Armin Braun; Katherina Sewald
Journal:  J Vis Exp       Date:  2018-05-09       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.